Cargando…
Notch3 overexpression enhances progression and chemoresistance of urothelial carcinoma
Abnormal activation of Notch signaling is involved in the etiology of various diseases, including cancer, but the association between Notch3 expression in urothelial cancer and clinical outcome remains unclear, and the molecular mechanisms underlying Notch3 signaling activation are not well defined....
Autores principales: | Zhang, Heng, Liu, Limei, Liu, Chungang, Pan, Jinhong, Lu, Gensheng, Zhou, Zhansong, Chen, Zhiwen, Qian, Cheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5470974/ https://www.ncbi.nlm.nih.gov/pubmed/28416766 http://dx.doi.org/10.18632/oncotarget.16156 |
Ejemplares similares
-
Long-Term Evaluation of Patients Undergoing Genitoplasty due to Disorders of Sex Development: Results from a 14-Year Follow-Up
por: Zhang, Heng, et al.
Publicado: (2013) -
Enhancer remodeling activates NOTCH3 signaling to confer chemoresistance in advanced nasopharyngeal carcinoma
por: Liu, Lizhen, et al.
Publicado: (2023) -
Connexin 26 is Down-Regulated by KDM5B in the Progression of Bladder Cancer
por: Li, Xin, et al.
Publicado: (2013) -
PRKD2 Promotes Progression and Chemoresistance of AML via Regulating Notch1 Pathway
por: Liu, Qian, et al.
Publicado: (2019) -
Canonical Notch signalling is inactive in urothelial carcinoma
por: Greife, Annemarie, et al.
Publicado: (2014)